I agree that this site is using cookies. You can find further informations here.
X
Torrente-López, Anabel
89  results:
Search for persons X
?
1

Comprehensive physicochemical and functional analysis of pe..:

Torrente-López, Anabel ; Hermosilla, Jesús ; Salmerón-García, Antonio...
European Journal of Pharmaceutics and Biopharmaceutics.  194 (2024)  - p. 131-147 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Comprehensive physicochemical characterization of a peptide..:

Pérez-Robles, Raquel ; Salmerón-García, Antonio ; Hermosilla, Jesus...
European Journal of Pharmaceutics and Biopharmaceutics.  184 (2023)  - p. 103-115 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-..:

Torrente-López, Anabel ; Hermosilla, Jesús ; Salmerón-García, Antonio..
Pharmaceutics.  14 (2022)  4 - p. 692 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Combined use of UV and MS data for ICH Stability-Indication..:

Torrente-López, Anabel ; Hermosilla, Jesús ; Pérez-Robles, Raquel...
Microchemical Journal.  182 (2022)  - p. 107896 , 2022
Link: https://doi.org/10.1016/..
 
?
5

QbD/PAT—State of the Art of Multivariate Methodologies in F..:

Pérez-Beltrán, Christian H. ; Jiménez-Carvelo, Ana M. ; Torrente-López, Anabel..
Food Engineering Reviews.  15 (2022)  1 - p. 24-40 , 2022
Link: https://doi.org/10.1007/..
 
?
6

The Relevance of Monoclonal Antibodies in the Treatment of ..:

Torrente-López, Anabel ; Hermosilla, Jesús ; Navas, Natalia...
Vaccines.  9 (2021)  6 - p. 557 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Use of subcutaneous tocilizumab to prepare intravenous solu..:

Navas, Natalia ; Hermosilla, Jesús ; Torrente-López, Anabel...
Journal of Pharmaceutical Analysis.  10 (2020)  6 - p. 532-545 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Comprehensive physicochemical characterization of a peptide..:

Pérez-Robles, Raquel ; Salmerón, Antonio ; Hermosilla, Jesús...
European Journal of Pharmaceutics and Biopharmaceutics;184.  , 2023
Link: https://hdl.handle.net/1..
 
?
9

Combined use of UV and MS data for ICH Stability-Indication..:

Torrente-Lopez, Anabel ; Hermosilla, Jesus ; Perez-Robles, Raquel...
0026-265X.  , 2022
Link: http://hdl.handle.net/10..
 
?
10

Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-..:

Torrente-López, Anabel ; Hermosilla, Jesús ; Salmerón-García, Antonio..
1999-4923.  , 2022
Link: http://hdl.handle.net/10..
 
?
11

The Relevance of Monoclonal Antibodies in the Treatment of ..:

Torrente-López, Anabel ; Hermosilla, Jesús ; Navas, Natalia...
2076-393X.  , 2021
Link: http://hdl.handle.net/10..
 
?
12

Use of subcutaneous tocilizumab to prepare intravenous solu..:

Navas, Natalia ; Hermosilla, Jesús ; Torrente-López, Anabel...
https://www.sciencedirect.com/science/article/pii/S2095177920304895?via%3Dihub.  , 2020
Link: http://hdl.handle.net/10..
 
?
13

Use of subcutaneous tocilizumab to prepare intravenous solu..:

Navas, Natalia ; Hermosilla, Jesús ; Torrente-López, Anabel...
http://hdl.handle.net/10668/16145.  , 2020
Link: http://hdl.handle.net/10..
 
?
14

Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-..:

Anabel Torrente-López ; Jesús Hermosilla ; Antonio Salmerón-García..
https://www.mdpi.com/1999-4923/14/4/692.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-..:

Anabel Torrente-López ; Jesús Hermosilla ; Antonio Salmerón-García..
Biopharmaceutics.  , 2022
Link: https://doi.org/10.3390/..
 
1-15